Enanta Pharmaceuticals
ENTA
ENTA
148 hedge funds and large institutions have $956M invested in Enanta Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 54 increasing their positions, 57 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less funds holding
Funds holding: 151 → 148 (-3)
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
76% less call options, than puts
Call options by funds: $1.29M | Put options by funds: $5.39M
Holders
148
Holding in Top 10
2
Calls
$1.29M
Puts
$5.39M
Top Buyers
| 1 | +$20.1M | |
| 2 | +$16M | |
| 3 | +$14.4M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$10.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.84M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$10M | |
| 3 | -$7.54M | |
| 4 |
Man Group
London,
United Kingdom
|
-$7.46M |
| 5 |
Renaissance Technologies
New York
|
-$6.59M |